Two recent articles that included the thoughts of nationally recognized COVID-19 experts attracted my attention this week. Combined, they provide cogent account of where hospitals, the health care system and our communities are now and the challenges ahead.
Last week, I wrote about COVID-19 vaccines. One story — a question and answer story in The New Yorker with Atul Gawande — relates to that issue. However, the context provided by the other — a column in The Washington Post by Ashish K. Jha — provides important context.
Missouri, and large parts of the nation, are seeing significant increases in COVID-19 positivity rates. Historically, these rates have been an indicator for future hospitalizations. According to Jha, the rates are correlating less since Nov. 1. Jha illustrates the disconnect saying, “On Nov. 1, the COVID Tracking Project’s seven-day average showed about 80,000 new cases — which we would predict should lead to about 2,800 new hospitalizations a week later, by Nov. 8. Instead, there were 2,600, a little fewer than expected. On Nov. 15, we had 146,000 new cases, which should have resulted in about 5,100 new hospitalizations by Nov. 22. However, there were fewer than 3,700. This pattern of declining rates of hospitalization continued through the end of November.”
Jha reasons that the disconnect between the ratio of positive cases and hospitalizations are related to capacity challenges resulting in “rationing” of bed space that earlier in the pandemic would not have been necessary. He explains further, “The decision whether to admit a patient depends on two things: clinical judgment and bed availability. Critically ill patients will always be admitted. But as hospitals start to fill up, less sick patients — younger COVID patients, or those whose oxygen levels haven’t yet sunk critically low — get sent home.”
As hospitals in Missouri reach maximum capacity, these decisions are being made in real time and with implications not only for patients, but the workforce. “Some health care workers are retiring or switching professions. Others are sharing tearful videos on social media, agonized by patients who refuse to believe in the disease that is killing them.” Jha wrote. “All of them are frustrated by the failure to take more effective action against the virus.”
This week’s announcement from the U.S. Food and Drug Administration that the Pfizer vaccine will receive emergency use authorization will be perceived by many as the beginning of a light at the end of the tunnel. Vaccines may arrive as early as next week, and when final federal authorization is received, health care workers on the front line will be among the first eligible recipients.
However, according to Gawande, we are far from the end of our struggle with the virus. He told The New Yorker, “This is an undertaking on another scale from anything we’ve been doing in the last year. We have deployed north of 120 million coronavirus tests in the course of eight months. This is going to be 330 million vaccinations, done twice, and hoping to accomplish it in the course of six months or less.”
We’re already seeing the last-minute complications in Missouri and are working through the state’s planning to help hospitals operationalize it.
Here’s what I think. We will continue to experience high rates of infection through the New Year’s holiday and will have significant capacity challenges throughout the winter months. A vaccine is not a panacea; it’s an important next step. The only way to address the capacity challenge is to double down on prevention efforts while we step up vaccination efforts. These two combined actions will help reduce the toll on health care workers and save a lot of lives.
We’ve reached a critical phase of the pandemic. However, we have some very difficult days ahead.
Congress Enacts Temporary Delay Of Federal Shutdown
Parson Administration, Legislature Release Consensus Revenue Estimate
CMS Proposes New Rules To Address Prior Authorizations And Reduce Burden On Patients
HRSA Releases 340B ADR Regulation
CMS Releases Marketplace Week Five Enrollment Data
MLN Connects Provider eNews Available
HIDI Releases Second Quarter CY 2020 Update To Discharge Data-Based Quality Indicators
Rural PREP Hosts Webinar On Rural Pipeline Programs
With ratification today by the U.S. Senate, Congress passed a one-week delay of a federal government shutdown slated to begin at midnight on Friday, Dec. 11. Through Friday, Dec. 18, Congress will work to negotiate and enact a longer extension of federal spending authority coupled with legislation largely focused on responding to the COVID-19 pandemic.
Gov. Parson announced yesterday that his budget office and leaders of the House and Senate budget committees have reached consensus on an estimate of general revenue collections for state fiscal years 2021 and 2022. The consensus revenue estimate marks the informal beginning of the development of the state’s FY 2022 budget. Parson will release his funding recommendations for the upcoming year to the legislature in his State of the State address in mid-January.
The estimates reflect the economic disruption caused by the COVID-19 pandemic. Revenues for FY 2021 are projected to grow by $1.4 billion, or 14.2% over FY 2020. This extraordinary high rate of growth primarily is the result of shifting the state income tax filing deadline, and hence significant collections, from April (SFY 2020) to July (SFY 2021). FY 2022 revenues are expected to fall $9.8 billion, a reduction of 4.1%, a reflection of the underlying weakness in general revenue collections.
The Centers for Medicare & Medicaid Services released a proposed rule that would “improve the electronic exchange of health care data among payers, providers and patients, and streamline processes related to prior authorization to reduce burden on providers and patients.” The proposed rule includes five sets of proposals.
require certain payers to implement a Fast Healthcare Interoperability Resource that includes information about the patient’s pending and active prior authorization decisions
require certain payers to build and maintain a Provider Access Application Programming Interface to help facilitate coordination of care by including payer-to-provider data sharing of claims and encounter data
proposals to make the prior authorization process more efficient and transparent, including a maximum of 72 hours to issue decisions, requirement to provide specific reasons for denials and make public certain metrics that demonstrate how many procedures are being authorized
expanding the payer-to-payer data exchange to increase data flow among certain payers
implementation specification proposals
Medicare Advantage plans are not included in the proposal. CMS is considering whether to include MA plans in future rulemaking. Comments about the proposed rule are due by 4 p.m. Monday, Jan. 4.
The Health Resources and Services Administration finalized regulations that establish a binding administrative dispute resolution process to settle disagreements between 340B-covered entities and drug manufacturers. While a formal ADR regulation is helpful, additional relief is needed. Drug manufacturers long have attacked the 340B Program, as most recently demonstrated by limiting the distribution of certain 340B drugs to hospitals or placing administratively costly reporting requirements.
The Centers for Medicare & Medicaid Services released marketplace enrollment data through Dec. 5. For the first five weeks of the 2021 open enrollment period, 3,818,665 beneficiaries made plan selections in states where the HealthCare.gov platform is being utilized. Through the fifth week of open enrollment for 2020, 2,876,998 plan selections had been chosen. In Missouri, 92,684 beneficiaries made plan selections for 2021, approximately 39.5% more than the 66,442 plan selections through the fifth week last year.
The Centers for Medicare & Medicaid Services issued updates to MLN Connects Provider eNews. eNews includes information about national provider calls, meetings, events, announcements and other MLN educational product updates. The latest issue provides updates and summaries of the following.
The Hospital Industry Data Institute refreshed the readmissions, hospital-acquired conditions and AHRQ quality indicators data within HIDI Analytic Advantage® PLUS to include measure calculations based on discharge data from the second quarter of calendar year 2020.
These quality data updates can be found in various reports in the following Analytic Advantage Plus locations.
Quality > Benchmarking
Quality > Readmissions
Quality > Strategic Quality Initiatives
For technical questions regarding these measures, please contact Josette Bax. For questions about accessing the website or running these reports, please contact HIDI.
Rural PREP is hosting a webinar, “Supporting Medical Education Reforms Through Data and Local Advocacy for Rural Pipelines,” at noon CST Thursday, Dec. 17, to discuss the role of “growing our own” health professionals and to highlight evaluation studies that support strategies for rural medical education. Rural PREP is a nonprofit organization promoting health professions training and research in rural communities.